A report published in the on-line version of The Lancet on April 20 says that "considerable gaps exist among European national pandemic plans." Taken from the London School of Hygiene and Tropical Medicine study of European pandemic preparedness, this concluded that further implementation is required to allow national governments to effectively respond.
The LSHTM report considered the pandemic management initiatives in all 25 European Union member states, as well as in Bulgaria, Norway, Romania and Sweden, specifically assessing: planning and coordination; surveillance; public health control measures such as vaccine and antiviral stocks; and health system response and communication. The assessment found that the completeness score of the plans across the EU ranged from 24% to 80%, with an average of 54%.
The research group added that it had only considered plans that were effective as of November 2005, and that action taken after this date may address some of the issues raised in its study.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze